Allworth Financial’s Gossamer Bio GOSS Stock Holding History

Allworth Financial’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4K	Buy	106 +46	+77%	+$1.03K	﹤0.01%	4628
2026 Q1	$1.58K	Buy	60 +35	+140%	+$4.4K	﹤0.01%	4423
2025 Q4	$6.24K	Buy	25 +13	+108%	+$2.97K	﹤0.01%	3577
2025 Q3	$2.61K	Buy	+12	New	+$2.12K	﹤0.01%	3884
2022 Q4	–	Sell	-1	Closed	-$1K	–	3080
2022 Q3	$1K	Buy	+1	New	+$993	﹤0.01%	2392
2021 Q2	–	Sell	-1	Closed	-$1K	–	1598
2021 Q1	$1K	Sell	1 -2	-67%	-$1.61K	﹤0.01%	1393
2020 Q4	$2K	Buy	+3	New	+$2.36K	﹤0.01%	1157

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Allworth Financial's GOSS Position: Q2 2026 in Review

Allworth Financial increased its Gossamer Bio (GOSS) stake by 77% in Q2 2026, buying an estimated $1.03K and bringing the position to 106 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

Allworth Financial first reported a position in GOSS in Q4 2020 and has held it in 7 quarters since. The position peaked at $6.24K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Allworth Financial held 106 shares of Gossamer Bio worth $1.4K as of Q2 2026.
Allworth Financial bought 46 Gossamer Bio shares in Q2 2026, an estimated $1.03K.
Gossamer Bio made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4628 holding.
Allworth Financial first reported a position in Gossamer Bio in Q4 2020 and has held it in 7 quarters since.
Allworth Financial's Gossamer Bio position peaked at $6.24K in Q4 2025.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.